comparemela.com

Latest Breaking News On - Department of medical oncology hematology - Page 1 : comparemela.com

Syncona : Anaveon announces publication of ANV419 Phase I data in The Journal for ImmunoTherapy of Cancer -December 14, 2023 at 04:04 am EST

ANV419 delivers high dose IL-2 to patients with a good safety and tolerability profile Anaveon, a clinical stage, immuno-oncology company, today announced the publication of.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.